24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Kadimastem
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
19:02
Germany signs second $3.1 billion Arrow missile deal with Israel
17:51
Full list of Israeli startup M&As in 2025
17:47
Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal
14:36
The AI revolution is already here - and this time, it’s not waiting for anyone
More stories
Buzz
Most popular
Daily
Weekly
1
Palo Alto Networks CEO: “We’re happy Wiz is now part of Google, it gives us more room to operate”
2
“Younger people are getting cancer more and more. We have to make kinder medicines.”
3
The $2.3 billion mystery arms deal Israel won’t explain
4
“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”
5
Cyera raises $400 million at $9 billion valuation in Blackstone-led round
More news
Kadimastem
2 stories about Kadimastem
Israeli and French Biotech Companies Partner to Fight Diabetes With Bio-Artificial Pancreas
12.11.18
|
Lilach Baumer
Israel-based Kadimastem and France-headquartered Defymed will receive a grant of around $1.5 million from the European Commission's Eurostars program to develop the technology to treat type 1 diabetes
Kadimastem Gets FDA Orphan Drug Designation for ALS Drug
04.11.18
|
Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019
